Profile data is unavailable for this security.
About the company
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
- Revenue in USD (TTM)230.59m
- Net income in USD-96.37m
- Incorporated1986
- Employees1.16k
- LocationSTAAR Surgical Co1911 Walker AveMONROVIA 91016United StatesUSA
- Phone+1 (626) 303-7902
- Fax+1 (302) 636-5454
- Websitehttps://www.staar.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of California Inc | 154.58m | -503.63m | 555.51m | 575.00 | -- | 15.39 | -- | 3.59 | -1.69 | -1.69 | 0.5236 | 0.1196 | 0.1372 | 1.80 | 5.15 | 268,841.80 | -44.70 | -16.31 | -47.29 | -17.71 | 30.95 | 34.48 | -325.80 | -156.40 | 5.40 | -19.94 | 0.947 | -- | -23.19 | 11.12 | -1.02 | -- | 16.89 | -- |
| Varex Imaging Corp | 854.40m | -67.70m | 560.62m | 2.40k | -- | 1.18 | -- | 0.6562 | -1.63 | -1.63 | 19.34 | 11.38 | 0.7032 | 1.85 | 6.00 | 356,000.00 | -5.55 | -0.3327 | -6.45 | -0.3955 | 34.15 | 33.16 | -7.89 | -0.4661 | 1.87 | 2.22 | 0.4321 | -- | 4.14 | 2.73 | -47.38 | -- | -0.5159 | -- |
| Tactile Systems Technology Inc | 311.51m | 18.17m | 591.00m | 1.04k | 34.06 | 2.88 | 23.73 | 1.90 | 0.7768 | 0.7768 | 13.28 | 9.18 | 1.14 | 8.38 | 8.07 | 300,398.30 | 6.64 | 1.29 | 7.72 | 1.55 | 49.87 | 49.12 | 5.83 | 1.26 | 3.20 | -- | 0.00 | 0.00 | 6.76 | 9.11 | -40.52 | 9.10 | -15.97 | -- |
| Embecta Corp | 1.08bn | 139.50m | 592.20m | 1.85k | 4.23 | -- | 3.27 | 0.5485 | 2.37 | 2.37 | 18.31 | -10.35 | 0.9757 | 2.27 | 6.35 | 583,621.60 | 12.61 | 16.69 | 16.60 | 22.65 | 63.17 | 66.74 | 12.92 | 15.71 | 1.87 | 3.18 | 1.79 | 13.07 | -3.80 | -0.1033 | 21.84 | -25.93 | -26.03 | -- |
| Beta Bionics Inc | 88.57m | -77.84m | 596.53m | 404.00 | -- | 2.02 | -- | 6.74 | -2.07 | -2.07 | 2.21 | 6.70 | 0.4149 | 2.54 | 8.16 | 304,364.30 | -36.46 | -- | -40.57 | -- | 54.51 | -- | -87.89 | -- | 9.83 | -- | 0.00 | -- | 442.93 | -- | -24.17 | -- | -- | -- |
| Alpha Tau Medical Ltd | 0.00 | -39.97m | 616.46m | 125.00 | -- | 7.95 | -- | -- | -0.5212 | -0.5212 | 0.00 | 0.9099 | 0.00 | -- | -- | 0.00 | -40.90 | -34.28 | -44.43 | -36.47 | -- | -- | -- | -- | -- | -- | 0.0735 | -- | -- | -- | -8.89 | -- | 11.60 | -- |
| SI-Bone Inc | 193.58m | -21.76m | 650.00m | 349.00 | -- | 3.77 | -- | 3.36 | -0.5113 | -0.5113 | 4.55 | 3.98 | 0.8393 | 1.29 | 7.53 | 554,664.80 | -9.43 | -24.17 | -10.61 | -26.87 | 79.62 | 82.72 | -11.24 | -40.93 | 6.62 | -- | 0.1711 | -- | 20.37 | 19.96 | 28.67 | -- | 33.83 | -- |
| Bioventus Inc | 563.83m | 7.82m | 670.38m | 950.00 | 72.11 | 4.04 | 11.69 | 1.19 | 0.1123 | 0.1123 | 8.39 | 2.01 | 0.7666 | 1.95 | 4.47 | 606,267.80 | 1.31 | -6.29 | 1.89 | -8.49 | 67.76 | 67.40 | 1.71 | -12.07 | 1.14 | 1.73 | 0.616 | -- | 11.89 | 11.00 | 65.33 | -- | -15.55 | -- |
| Avanos Medical Inc | 699.90m | -468.60m | 685.14m | 2.23k | -- | 0.8806 | -- | 0.9789 | -10.18 | -10.18 | 15.09 | 16.76 | 0.5139 | 2.14 | 5.76 | 314,279.30 | -34.41 | -4.82 | -39.66 | -5.42 | 52.28 | 54.01 | -66.95 | -11.32 | 1.36 | 8.92 | 0.1167 | -- | 2.15 | -0.2826 | -3,802.02 | -- | -18.86 | -- |
| CeriBell Inc | 82.81m | -52.46m | 739.69m | 281.00 | -- | 4.50 | -- | 8.93 | -1.45 | -1.45 | 2.29 | 4.43 | 0.6717 | 1.54 | 6.36 | 294,708.20 | -42.55 | -- | -48.06 | -- | 87.99 | -- | -63.35 | -- | 12.25 | -29.42 | 0.1074 | -- | 44.71 | -- | -37.30 | -- | -- | -- |
| Butterfly Network Inc | 88.45m | -79.87m | 770.44m | 190.00 | -- | 3.78 | -- | 8.71 | -0.3347 | -0.3347 | 0.3729 | 0.8071 | 0.3186 | 0.7409 | 3.93 | 465,515.80 | -28.77 | -- | -34.57 | -- | 43.24 | -- | -90.31 | -190.03 | 3.56 | -- | 0.00 | -- | 24.52 | -- | 45.78 | -- | -- | -- |
| STAAR Surgical Co | 230.59m | -96.37m | 820.24m | 1.16k | -- | 2.30 | -- | 3.56 | -1.96 | -1.96 | 4.64 | 7.17 | 0.464 | 1.29 | 2.80 | 199,300.80 | -19.39 | 3.81 | -22.26 | 4.42 | 73.87 | 77.03 | -41.79 | 5.42 | 4.35 | -- | 0.00 | 0.00 | -2.64 | 15.89 | -194.66 | -- | 18.11 | -- |
| Integra Lifesciences Holdings Corp | 1.64bn | -495.34m | 842.01m | 4.40k | -- | 0.8109 | -- | 0.5125 | -6.46 | -6.46 | 21.45 | 13.33 | 0.4261 | 1.52 | 6.34 | 373,741.10 | -12.85 | 2.90 | -15.39 | 3.25 | 57.21 | 62.59 | -30.15 | 7.14 | 1.80 | 2.68 | 0.6383 | 0.00 | 4.47 | 1.20 | -110.25 | -- | -3.19 | -- |
| Inmode Ltd | 370.50m | 93.83m | 906.03m | 660.00 | 9.91 | 1.33 | 9.58 | 2.45 | 1.44 | 1.44 | 5.67 | 10.78 | 0.4774 | 1.19 | 9.28 | 561,356.10 | 12.09 | 24.21 | 13.30 | 26.82 | 78.54 | 82.36 | 25.33 | 38.64 | 8.83 | -- | 0.00 | 0.00 | -6.16 | 12.44 | -48.24 | 4.57 | 15.99 | -- |
| Castle Biosciences Inc | 343.53m | -12.24m | 931.12m | 761.00 | -- | 1.99 | 30.50 | 2.71 | -0.4533 | -0.4533 | 11.67 | 16.02 | 0.6377 | 9.05 | 6.89 | 451,419.20 | -2.27 | -6.95 | -2.50 | -7.52 | 79.94 | 80.76 | -3.56 | -17.49 | 6.31 | -- | 0.0218 | -- | 51.09 | 44.97 | 131.75 | 43.57 | 97.74 | -- |
| BioLife Solutions Inc | 88.83m | -13.99m | 1.04bn | 159.00 | -- | 2.93 | -- | 11.70 | -0.2922 | -0.061 | 1.87 | 7.37 | 0.2296 | 0.8875 | 6.18 | 558,698.10 | -3.62 | -1.92 | -3.92 | -2.10 | 70.02 | 52.54 | -15.75 | -9.06 | 3.64 | -- | 0.0207 | -- | 8.44 | 24.62 | 38.27 | -- | 19.15 | -- |
Data as of Feb 12 2026. Currency figures normalised to STAAR Surgical Co's reporting currency: US Dollar USD
74.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Broadwood Capital, Inc.as of 14 Jan 2026 | 15.45m | 31.07% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 6.58m | 13.23% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.85m | 7.75% |
| Yunqi Capital Ltd.as of 14 Jan 2026 | 3.26m | 6.55% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 1.91m | 3.84% |
| Balyasny Asset Management LPas of 30 Sep 2025 | 1.81m | 3.65% |
| Magnetar Financial LLCas of 30 Sep 2025 | 1.20m | 2.42% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.17m | 2.36% |
| Goldman Sachs & Co. LLC (Private Banking)as of 30 Sep 2025 | 863.00k | 1.74% |
| Sand Grove Capital Management LLPas of 30 Sep 2025 | 829.12k | 1.67% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
